» Articles » PMID: 8467233

Platelet Alpha-granules

Overview
Journal Blood Rev
Publisher Elsevier
Specialty Hematology
Date 1993 Mar 1
PMID 8467233
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

Platelets contain a vast number of biologically active molecules within cytoplasmic granules which are classified according to their respective distinct ultrastructures, densities and content. The alpha-granule is a unique secretory organelle in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG). The currently known list of alpha-granular proteins continues to enlarge and includes many adhesive proteins (e.g. Fg, von Willebrand factor (vWf) and thrombospodin (TSP)), plasma proteins (e.g. IgG and albumin), cellular mitogens (e.g. platelet derived growth factor and TGF beta), coagulation factors (e.g. factor V) and protease inhibitors (e.g. alpha 2-macroglobulin and alpha 2-antiplasmin). More recently the inner lining of the alpha-granule unit membrane has been demonstrated to contain a number of physiologically important receptors including glycoprotein IIb/IIIa (alpha IIb beta 3) and P-selectin. The alpha-granules originate from small precursor granules which can be observed budding from the trans-Golgi network within the platelet precursor cell the MK. During MK maturation the alpha-granules become very prominent and are ultimately packaged into platelets during thrombopoiesis. The alpha-granular contents are destined for release during platelet activation at sites of vessel wall injury and thus play an important role in haemostasis, inflammation, ultimate wound repair and in the pathogenesis of atherosclerosis.

Citing Articles

The Mechanisms of Sepsis Induced Coagulation Dysfunction and Its Treatment.

Zhu L, Dong H, Li L, Liu X J Inflamm Res. 2025; 18:1479-1495.

PMID: 39925935 PMC: 11804232. DOI: 10.2147/JIR.S504184.


The Role of Platelet Concentrates and Growth Factors in Facial Rejuvenation: A Systematic Review with Case Series.

Malcangi G, Inchingolo A, Inchingolo A, Ferrante L, Latini G, Trilli I Medicina (Kaunas). 2025; 61(1).

PMID: 39859067 PMC: 11767021. DOI: 10.3390/medicina61010084.


Revisiting Virchow's triad: exploring the cellular and molecular alterations in cerebral venous congestion.

Zhou C, Zhou Y, Ma W, Liu L, Zhang W, Li H Cell Biosci. 2024; 14(1):131.

PMID: 39444013 PMC: 11515517. DOI: 10.1186/s13578-024-01314-5.


A modern overview of the process of platelet formation (thrombocytopoiesis) and its dependence on several factors.

Ivanovna Gabrilchak A, Anatolievna Gusyakova O, Aleksandrovich Antipov V, Alekseevna Medvedeva E, Leonidovna Tukshumskaya L Biochem Med (Zagreb). 2024; 34(3):030503.

PMID: 39435166 PMC: 11493462. DOI: 10.11613/BM.2024.030503.


One immune cell to bind them all: platelet contribution to neurodegenerative disease.

Rodriguez Moore G, Melo-Escobar I, Stegner D, Bracko O Mol Neurodegener. 2024; 19(1):65.

PMID: 39334369 PMC: 11438031. DOI: 10.1186/s13024-024-00754-4.